Literature DB >> 24375318

Emerging role of nanog in tumorigenesis and cancer stem cells.

Luis E Iv Santaliz-Ruiz1, Xiujie Xie, Matthew Old, Theodoros N Teknos, Quintin Pan.   

Abstract

Nanog is a transcription factor that is well-established as a key regulator of embryonic stem cell (ESC) maintenance. Recent evidence demonstrates that Nanog is dysregulated and intimately involved in promoting tumorigenesis in part through regulation of the cancer stem cell (CSC) population. Elevated Nanog is associated with poorer outcome in numerous epithelial malignancies. Nanog is enriched in CSCs and ablation of Nanog is sufficient to reduce the CSC pool. Nanog has also been implicated to promote chemoresistance and epithelial-mesenchymal transition (EMT). Insight into the Nanog signaling cascade, upstream regulators and downstream effectors, is beginning to emerge but remains to be fully elucidated. This review highlights the current literature on the emerging role of Nanog in tumorigenesis and CSCs.
© 2013 UICC.

Entities:  

Keywords:  Nanog; cancer initiating cells; cancer stem cells; epithelial-mesenchymal transition; prognostic biomarkers

Mesh:

Substances:

Year:  2014        PMID: 24375318      PMCID: PMC4065638          DOI: 10.1002/ijc.28690

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  68 in total

1.  Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.

Authors:  Juanjuan Shan; Junjie Shen; Limei Liu; Feng Xia; Chuan Xu; Guangjie Duan; Yanmin Xu; Qinghua Ma; Zhi Yang; Qianzhen Zhang; Leina Ma; Jia Liu; Senlin Xu; Xiaochu Yan; Ping Bie; Youhong Cui; Xiu-wu Bian; Cheng Qian
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

2.  Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.

Authors:  Te Liu; Fuhui Xu; Xiling Du; Dongmei Lai; Tianjin Liu; Yarui Zhao; Qin Huang; Lizhen Jiang; Wenbin Huang; Weiwei Cheng; Zhixue Liu
Journal:  Mol Cell Biochem       Date:  2010-03-12       Impact factor: 3.396

3.  MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation.

Authors:  Cheng-Chia Yu; Yi-Wei Chen; Guang-Yuh Chiou; Lo-Lin Tsai; Pin-I Huang; Charn-Yung Chang; Ling-Ming Tseng; Shih-Hwa Chiou; Sang-Hue Yen; Ming-Yung Chou; Pen-Yuan Chu; Wen-Liang Lo
Journal:  Oral Oncol       Date:  2011-02-02       Impact factor: 5.337

4.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

Authors:  Shih-Hwa Chiou; Mong-Lien Wang; Yu-Ting Chou; Chi-Jen Chen; Chun-Fu Hong; Wang-Ju Hsieh; Hsin-Tzu Chang; Ying-Shan Chen; Tzu-Wei Lin; Han-Sui Hsu; Cheng-Wen Wu
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

5.  Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma.

Authors:  Ting Lin; Yan-Qing Ding; Jian-Ming Li
Journal:  Med Oncol       Date:  2011-02-20       Impact factor: 3.064

6.  NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway.

Authors:  Chun Sun; Lu Sun; Kai Jiang; Dong-Mei Gao; Xiao-Nan Kang; Cun Wang; Shu Zhang; Shan Huang; Xue Qin; Yan Li; Yin-Kun Liu
Journal:  Int J Biochem Cell Biol       Date:  2013-03-07       Impact factor: 5.085

7.  Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.

Authors:  Shih-Hwa Chiou; Cheng-Chia Yu; Chi-Yang Huang; Shu-Chun Lin; Chung-Ji Liu; Tung-Hu Tsai; Shiu-Huey Chou; Chian-Shiu Chien; Hung-Hai Ku; Jeng-Fan Lo
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

8.  Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer.

Authors:  Cheng-Wei Lin; Mei-Yin Liao; Wen-Wei Lin; Yi-Ping Wang; Tung-Yin Lu; Han-Chung Wu
Journal:  J Biol Chem       Date:  2012-09-18       Impact factor: 5.157

9.  Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma.

Authors:  Chao Chen; Yan Wei; Michael Hummel; Thomas K Hoffmann; Manfred Gross; Andreas M Kaufmann; Andreas E Albers
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

10.  Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.

Authors:  Ping Wang; Quanli Gao; Zhenhe Suo; Else Munthe; Steinar Solberg; Liwei Ma; Mengyu Wang; Nomdo Anton Christiaan Westerdaal; Gunnar Kvalheim; Gustav Gaudernack
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

View more
  63 in total

1.  Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells.

Authors:  Behzad Mansoori; Ali Mohammadi; Fereydoon Abedi-Gaballu; Soheil Abbaspour; Mehri Ghasabi; Reza Yekta; Solmaz Shirjang; Gholamreza Dehghan; Michael R Hamblin; Behzad Baradaran
Journal:  J Cell Physiol       Date:  2020-01-28       Impact factor: 6.384

2.  ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.

Authors:  Xiaoming Zhu; Xiaobin Guo; Sen Wu; Li Wei
Journal:  Lung       Date:  2016-05-11       Impact factor: 2.584

Review 3.  Common stemness regulators of embryonic and cancer stem cells.

Authors:  Christiana Hadjimichael; Konstantina Chanoumidou; Natalia Papadopoulou; Panagiota Arampatzi; Joseph Papamatheakis; Androniki Kretsovali
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

4.  Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.

Authors:  Lina Sun; Kevin Beggs; Prachi Borude; Genea Edwards; Bharat Bhushan; Chad Walesky; Nairita Roy; Michael W Manley; Sumedha Gunewardena; Maura O'Neil; Hua Li; Udayan Apte
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-05-05       Impact factor: 4.052

5.  Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients.

Authors:  Ka Chen; Hongliang Liu; Zhensheng Liu; Sheng Luo; Edward F Patz; Patricia G Moorman; Li Su; Sipeng Shen; David C Christiani; Qingyi Wei
Journal:  Int J Cancer       Date:  2019-02-01       Impact factor: 7.396

6.  Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells.

Authors:  J Kim; Y Liu; M Qiu; Y Xu
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

Review 7.  Current status in cancer cell reprogramming and its clinical implications.

Authors:  Kenan Izgi; Halit Canatan; Banu Iskender
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-12       Impact factor: 4.553

8.  Ovarian Cancer Stem Cells: Unraveling a Germline Connection.

Authors:  Seema C Parte; Andrei Smolenkov; Surinder K Batra; Mariusz Z Ratajczak; Sham S Kakar
Journal:  Stem Cells Dev       Date:  2017-11-28       Impact factor: 3.272

9.  Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.

Authors:  Chuanzhao Zhang; Debangshu Samanta; Haiquan Lu; John W Bullen; Huimin Zhang; Ivan Chen; Xiaoshun He; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-21       Impact factor: 11.205

10.  SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.

Authors:  Jinfang Zhang; Ming Chen; Yasheng Zhu; Xiangpeng Dai; Fabin Dang; Junming Ren; Shancheng Ren; Yulia V Shulga; Francisco Beca; Wenjian Gan; Fei Wu; Yu-Min Lin; Xiaobo Zhou; James A DeCaprio; Andrew H Beck; Kun Ping Lu; Jiaoti Huang; Cheryl Zhao; Yinghao Sun; Xu Gao; Pier Paolo Pandolfi; Wenyi Wei
Journal:  Dev Cell       Date:  2018-12-27       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.